ABSTRACT
Introduction
Infections are becoming more difficult to treat, at least partly on account of microbes that produce biofilms. Reports suggest that decreased levels of antimicrobial peptides like cathelicidin, elevated levels of inflammatory cytokines, and biofilm formation are all associated with vitamin D deficiency, making vitamin D – deficient individuals more susceptible to infection. Infections attributable to biofilm-producing microbes can be managed by adjuvant therapy with vitamin D because of its immunomodulatory role, particularly because of the ability of vitamin D-pathway to induce the antimicrobial peptides like cathelicidin and decrease proinflammatory cytokines.
Areas covered
This narrative review covers biofilm formation, infections associated with biofilm due to vitamin D deficiency, putative role of vitamin D in host protection and the effect of vitamin D supplementation in biofilm-associated infections. A comprehensive literature search in PubMed and Google Scholar utilizing suitable keywords at multiple time points extracted relevant articles
Expert Opinion
Although vitamin D deficiency has been associated with infections by biofilm producing microbes, comprehensive clinical trials in various ethnicities are required to understand the likely relationships between vitamin D receptor gene expression, cathelicidin levels, and infection outcome. Current evidence hypothesizes that maintaining normal vitamin D level can help prevent and treat these infections.
Article highlights
Infections are becoming more difficult to treat, partly due to microbes that produce biofilms.
Decreased levels of antimicrobial peptides like cathelicidin, elevated levels of inflammatory cytokines, and biofilm formation are all associated with vitamin D deficiency, making vitamin D-deficient individuals more susceptible to biofilm-associated infections.
Much evidence implicates vitamin D’s immunomodulatory role in balancing the proinflammatory and anti-inflammatory aspects of the immune system and attenuating the cytokine storm in such infections.
There is some evidence that vitamin D adjuvant therapy, in addition to standard care, can improve outcomes because the vitamin D-pathway can significantly increase the expression of antimicrobial peptides (e.g. cathelicidin) during microbial invasion.
This review chiefly correlates biofilm-associated infections with vitamin D deficiency and collates evidence demonstrating the benefits of adding vitamin D as an adjuvant in the treatment guidelines to manage these types of infections.
Abbreviation
ABPA | = | Allergic bronchopulmonary aspergillosis |
ASL | = | Airway surface liquid |
CAP | = | Community-acquired pneumonia |
CD | = | Cluster of differentiation |
COX | = | Cyclooxygenase |
CPA | = | Chronic pulmonary aspergillosis |
CYP | = | Cytochrome P450 |
DFU | = | Diabetic foot ulcer |
EPM | = | Extracellular polymeric matrix |
IFN-γ | = | Interferon-γ |
Ig | = | Immunoglobulin |
IL-4 | = | Interleukin 4 |
LPS | = | Lipopolysaccharide |
MHC | = | Major histocompatibility complex |
NETs | = | Neutrophil extracellular traps |
OD | = | Once daily |
RCT | = | Randomized controlled trial |
RTI | = | Respiratory tract infection |
RXR | = | Retinoid X receptor |
spp | = | Species |
TNF | = | Tumor necrosis factor |
Th | = | Helper T cells |
TLR2 | = | Toll like receptor 2 |
TLRs | = | Toll-like receptors |
Treg | = | Regulatory T cells |
UTI | = | Urinary tract infections |
VDBP | = | Vitamin D binding protein; |
VDR | = | Vitamin D receptor; |
VDRE | = | Vitamin D response elements |
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or material discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or mending, or royalties.
Reviewer disclosures
Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.